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Abstract
Magnetic resonance spectroscopy (MRS) provides a valuable tool to non-invasively detect brain 
gamma-amino butyric acid (GABA) in vivo. GABAergic dysfunction has been observed in the 
aging cerebellum. Studying cerebellar GABA changes is of considerable interest in understanding 
certain age-related motor disorders. However, little is known about the reproducibility of GABA 
MRS in an aged population. Therefore, this study aimed to explore the feasibility and 
reproducibility of GABA MRS in the aged cerebellum at 3.0 Tesla and to examine the effect of 
differing tissue composition on GABA measurements. MRI and 1H MRS exams were performed 
on 10 healthy elderly volunteers (mean age 75.2 years ± 6.5 years) using a 3.0 Tesla Siemens Tim 
Trio scanner. Among them, 5 subjects were scanned twice to assess short-term reproducibility. 
The MEGA-PRESS J-editing sequence was used for GABA detection in two volumes of interest 
(VOIs) in left and right cerebellar dentate. MRS data processing and quantification were 
performed with LCModel 6.3-0L using two separate basis sets, generated from density matrix 
simulations using published values for chemical shifts and J-couplings. Raw metabolite levels 
from LCModel outputs were corrected for cerebrospinal fluid contamination and relaxation. 
GABA-edited spectra yielded robust and stable GABA measurements with averaged intra-
individual coefficients of variation for corrected GABA+ between 4.0 ± 2.8 % to 13.4 ± 6.3 % and 
inter-individual coefficients of variation between 12.6 % and 24.2 %. In addition, there was a 
significant correlation between GABA+ obtained with the two LCModel basis sets. Overall our 
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results demonstrated the feasibility and reproducibility of cerebellar GABA-edited MRS at 3.0 
Tesla in an elderly population. This information might be helpful for studies that use this 
technique to study GABA changes in normal or diseased aging brain, e.g., for power calculations 
and interpretation of longitudinal observations.
Keywords
magnetic resonance spectroscopy (MRS); gamma-amino butyric acid (GABA); aging brain; 
reproducibility; partial volume correction
INTRODUCTION
The precise balance between excitatory and inhibitory neurotransmitter systems is critical 
for maintaining the function of the central nervous system. Inhibition is mediated by 
gamma-amino butyric acid (GABA) through actions on both ionotropic and metabotropic 
receptors. In the developing nervous system, GABA plays a key role in modulating neural 
progenitor proliferation, cell migration, and circuit formation (1). In the normal aging brain, 
decrease in GABAergic parameters, such as reduced GABA current amplitude and loss in 
GABA-immunopositive neurons, is known to affect brain functions such as visual acuity 
and orientation sensitivity (2–5). Moreover, disturbances of the GABA neurotransmitter 
system have been implicated in many neurological and psychiatric diseases, including 
epilepsy (6), mood and anxiety disorders (7,8), sleep disorders (9), schizophrenia (10), 
autism (11) and essential tremor (12). Understanding in vivo GABA changes would provide 
important insights into the mechanism of age-related brain function deficits and the role of 
GABA in various disease models, as well as aid in potential treatment evaluations.
Currently, magnetic resonance spectroscopy (MRS) provides a valuable tool to non-
invasively detect brain metabolites in vivo. While it has proven to be difficult to reliably 
measure in vivo GABA due to its low concentration and spectral overlap with other more 
abundant metabolites, several methods have been adapted to successfully measure GABA, 
among which the most frequently used is the MEGA-PRESS sequence (13–15). Indeed, 
MRS studies have shown GABA perturbation in the above mentioned neurological and 
psychiatric diseases (16–21). Several groups also reported age-associated decreases in brain 
GABA levels in humans and rodents (22,23). In addition, reduced cortical GABA was 
demonstrated in elderly patients with mild cognitive impairment (24). A better 
understanding of the reproducibility of the technique in an aged population would aid in 
associating these changes to motor, sensory and cognitive deficits.
Several studies reported within-session, short-term and long-term reproducibility of brain 
GABA MRS measurements, with coefficients of variation (CVs) differing across studies, 
but generally less than 20%, depending on brain regions, acquisition parameters and spectral 
fitting tools (25–32). However, all of these studies recruited a young subject population 
(mean age of these eight studies: 29 years). The aging brain is known to suffer from 
substantial structural and neurochemical changes compared to the young brain (33). Losses 
in brain tissue volumes due to age-related atrophy also differ substantially between white 
matter (WM), gray matter (GM) and cerebrospinal fluid (CSF) (34). Therefore, the results 
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obtained from the young population may not be generalized to an elderly population. 
Assessment of the reproducibility of GABA MRS measurements and effects of tissue 
composition in an elderly population might provide new and relevant information for studies 
that explore GABA changes in normal and diseased aging brain regions. For example, one 
region of interest is the cerebellum, which does not only show age-related volumetric 
change, but is also involved in age-related motor deficits, learning function and processing 
speed decline (33,35–37). GABAergic dysfunction has been observed in the aging 
cerebellum and seems to be of great interest in age-related motor and cognitive deficits (38–
40). One of the potential targets is to study essential tremor, the most common cause of 
tremor in humans. Increased 11C-flumazenil binding at GABAergic receptor sites was 
reported by a positron emission tomography study (38), suggesting the potential 
involvement of GABA activity in essential tremor.
The aims of the current analyses were to 1) explore the feasibility and reproducibility of 
GABA-edited spectroscopy in the aged cerebellum at 3.0 Tesla, 2) examine the effect of 
tissue composition on GABA measurements.
MATERIALS AND METHODS
Subjects
A group of 10 healthy elderly volunteers (three males, seven females; age: mean ± standard 
deviation [SD], 75.2 ± 6.5 years, ranging from 65 to 86 years) were recruited as part of a 
longitudinal study of brain GABA in patients with essential tremor and age-matched healthy 
elderly volunteers. All healthy elderly volunteers underwent a structured clinical interview 
to rule out any neurological or psychiatric diseases as well as a detailed videotaped 
neurological examination that was reviewed by a senior movement disorder neurologist 
(EDL) to rule out the presence of essential tremor, Parkinson’s disease or other disorders of 
involuntary movement. None of the volunteers was taking medication that could increase 
brain GABA concentration (e.g., clonazepam, primidone) or had a history of heavy exposure 
to ethanol, as previously defined (41). To assess short-term intra-individual reproducibility, 
5 healthy volunteers were scanned twice with varied time intervals ranging from 2 to 28 
days (Mean ± SD: 10.8 ± 8.9 days). The study protocol was reviewed and approved by the 
Human Subjects Institutional Review Board at Columbia University, Yale University, 
Purdue University and at Weill Cornell Medical College. Written informed consent was 
obtained from each subject prior to participation in the study.
In vivo MRI/MRS measurements
MRI and 1H MRS exams were performed on a 3.0 Tesla Siemens Tim Trio scanner 
(Siemens Healthcare, Erlangen, Germany), equipped with a 32-channel head coil. Fast T2-
weighted images were acquired in all three orientations to ensure exact localization of the 
MRS volumes of interest (VOIs). Short-TE 1H spectra (PRESS localization; TR/TE = 
1500/30 ms; CHESS water suppression) were acquired in four volumes of interest (VOIs): 
left and right cerebellar cortex (both 15 mm × 15 mm × 25 mm, 128 averages), and left and 
right cerebellar dentate nucleus (both 25 mm × 25 mm × 25 mm, 128 averages) (Figure 1). 
For all of the VOIs, a reference spectrum was acquired without water suppression. These 
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reference spectra were then used for phase and frequency correction of the corresponding 
water-suppressed spectra. FASTESTMAP shimming (IPR#577; Siemens Healthcare) was 
performed before each voxel measurement to achieve water line widths of < 20 Hz (42). The 
MEGA-PRESS J-editing sequence was used for GABA detection (TR/TE = 1500/68 ms) 
(13,14) in two of the four VOIs described above. MEGA-PRESS spectra were only acquired 
in the right and left dentate nucleus, given the fact that this is the level at which the Purkinje 
cells release their GABA into the synaptic cleft (43). 196 averages were acquired with the 
spectrally selective editing pulse centered at 1.9 ppm (edit-on) and 196 averages with the 
pulse centered at 7.5 ppm (edit-off) in an interleaved fashion. The resulting difference 
spectrum contains a GABA peak at 3.0 ppm, which also includes contributions from co-
edited macromolecules and homocarnosine, a dipeptide consisting of GABA and histidine. 
Therefore, the signal will be referred to as GABA+. In order to determine voxel tissue 
composition, high-resolution MPRAGE images were acquired (TR/TE/TI = 2300/2.91/900 
ms, flip angle = 9°, bandwidth: 240 Hz/pixel, voxel size: 1.0 mm × 1.0 mm × 1.2 mm, 
GRAPPA = 2). Every effort was made to ensure the subjects were as comfortable as 
possible in the scanner. The dentate nucleus was clearly identified on the T2-weighted 
images on both axial and coronal planes. The GABA voxel was placed on the axial plane 
such that the entire dentate nucleus was included while minimizing contributions from 
vascular and CSF compartments. The voxel was then confirmed to be completely within the 
cerebellum on the coronal plane. The voxel placed in the cerebellar cortex was placed in the 
posterior cortex of the axial plane and the superior cortex on the coronal place. The voxel 
was angled to follow the edge of the cerebellar cortex in both axial and coronal planes. 
Placement was then confirmed to be completely contained within the cerebellum on the 
sagittal plane. Using this prescription allowed for reproducible placement of voxels across 
subjects and in repeat scans.
Data processing and analysis
MRS data processing and quantification were performed with LCModel 6.3-0L (44), fitting 
each spectrum as a weighted linear combination of basis spectra from individual 
metabolites. For the short-TE spectra, a basis set of in vitro spectra from individual 
metabolite solutions was used. For the MEGA-PRESS spectra, basis sets were generated 
from density matrix simulations of the sequence using two sets of published values for 
chemical shifts and J-couplings from Govindaraju et al. and Kaiser et al. (45,46), with an 
exact treatment of metabolite evolution during the two frequency-selective MEGA inversion 
pulses. These two sets of chemical shift and J-coupling values (Table 1), one from an early 
publication reporting multiple metabolites and one from a later publication for refining 
GABA values, have been used extensively in GABA spectroscopy studies to date. 
Therefore, we chose to analyze our MEGA-PRESS spectra with two separate basis sets that 
employed both sets of values, and to further test their relationship. The two basis sets are 
denoted as “Govindaraju basis set” and “Kaiser basis set”, or abbreviated as G basis set and 
K basis set, respectively. Difference basis spectra were obtained by subtracting the 
simulated metabolite response to selective inversion at 7.5 ppm from that at 1.9 ppm.
Full width half maximum (FWHM) and signal to noise ratio (S/N) were checked to ensure 
consistent spectral quality. Two sets of short-TE spectra from the cerebellar cortex VOIs 
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were excluded from further analysis due to insufficient water suppression. LCModel fitting 
%SD values for our metabolites of interest - creatine (Cr), N-acetyl aspartate (NAA) and 
glutamate (Glu) - were lower than 10 %, and GABA+ lower than 20 %.
In order to compare results with previous published reports, the ratios of GABA+ over Cr 
and NAA were also calculated. While raw GABA+/NAA values were directly given by 
LCModel outputs, raw GABA+ values were derived from raw water-scaled GABA+ output 
values, multiplied by a water scaling factor. Cr levels were obtained from spectra with the 
MEGA-PRESS editing pulse centered at 7.5 ppm, in order to calculate the ratios of GABA
+/Cr. To determine the tissue composition of the voxels, MPRAGE images were segmented 
into GM, WM and CSF using an in-house MATLAB 2013a tool (MathWorks Inc., Natick, 
MA, USA) incorporated with statistical parametric mapping (SPM8, Wellcome Department 
of Imaging Neuroscience, London, United Kingdom). One segmentation example of a 
dentate nucleus voxel is shown in Figure 2. Metabolite levels corrected for CSF and 
relaxation were obtained using the following equation (47,48),
where Mcor is the corrected value, Mraw is the uncorrected value, VISw is a correcting 
factor for MR water visibility (0.65), T2m is the T2 relaxation time of the metabolite, and 
fGM, fWM and fCSF are the fraction of GM, WM and CSF within the voxel, respectively. 
The term (43300 × fGM + 35880 × fWM + 55556 × fCSF)/35880 is included to adjust for 
voxel water concentration, where the LCModel default water concentration is 35880. CSF 
contamination is corrected for by the term 1/(1−fCSF). LCModel estimates T1 relaxation 
correction through  when water scaling is used. Therefore, no 
additional correction for T1 relaxation was performed. T2 of GABA, Cr, NAA, Glu and 
water were chosen to be 88, 154, 259, 181 and 95 ms, respectively (49–51). For GABA, raw 
output from the difference spectrum should be multiplied by FCALIB factor, which can be 
obtained from the .PRINT file from the edit-off spectrum analysis to estimate water scaled 
concentration. Corrected metabolite ratios were calculated from corrected GABA+ divided 
by corrected Cr and corrected NAA, respectively. Both raw and corrected levels are 
reported.
Statistics
Results from a total of 30 GABA-edited spectra from the cerebellar dentate, 30 short-TE 
spectra from the cerebellar dentate and 28 from the cerebellar cortex were analyzed. 
Statistical analyses were performed using SPSS 21.0 (IBM Corp., Armonk, NY, USA). All 
metabolites of interest were found to be normally distributed, as assessed by the Shapiro-
Wilk test (p > 0.05). Descriptive values are reported (mean, SD). CVs for each of the 5 
individuals who underwent two scans were calculated and averaged as an estimate of intra-
individual reproducibility, while CVs for all subjects were calculated as an estimate of inter-
individual reproducibility for each metabolite of interest. Metabolite levels were compared 
between left and right corresponding VOIs using Student’s t-tests. Pearson’s correlation was 
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used to estimate the relationship between combined left and right corrected GABA+, versus 
raw GABA+, GABA+/Cr and GABA+/NAA measurements. The correlations between 
combined left and right NAA and Glu in cerebellar dentate and cortex were also determined, 
respectively, in order to compare with one previous publication, which found a significant 
correlation in young subjects (52). In order to compare the performance of the two basis 
sets, pairwise Wilcoxon signed rank tests were used to test the mean values of all raw and 
corrected GABA+ measurements, and the corresponding inter- and intra-individual CVs 
between using the two basis sets. Bonferroni correction was employed to correct for 
multiple comparisons.
RESULTS
Figure 1 shows representative VOI placements for right cerebellar cortex and dentate, as 
well as pairs of right cerebellar GABA-edited difference spectra from 5 subjects. GABA+ 
measurements (GABA+, GABA+/Cr and GABA+/NAA) including raw and corrected 
values using two sets of LCModel analysis are reported in Table 2. Intra-individual CVs for 
the repeated GABA+ measurements (raw and corrected GABA+, GABA+/Cr and GABA+/
NAA) range from 4.0 ± 2.8 % to 13.9 ± 6.9 %, whereas inter-individual CVs range from 
12.6 % to 27.0 %. Overall correction for CSF contamination and relaxation did not 
significantly improve the CVs. No difference was observed between left and right cerebellar 
dentate GABA+ levels. Corrected Cr, NAA and Glu levels obtained from the short-TE 
spectra in all four VOIs are shown in Table 3. Intra-individual CVs for these corrected 
metabolites were lower than 5.5 ± 0.5 %, while inter-individual CVs were lower than 15.4 
%. NAA levels were significantly higher in the left than in the right cerebellar cortex (p < 
0.001). In addition, there was a significant correlation between NAA and Glu in the 
cerebellar cortex (R = 0.699, p < 0.01), but not in the dentate.
Figure 3 shows the individual corrected GABA+ levels in left and right cerebellar dentate 
from all subjects using two LCModel basis sets, with 5 of them scanned twice for assessing 
short-term reproducibility. Using the Kaiser basis set, corrected GABA+ significantly 
correlated with raw GABA+, GABA+/Cr and GABA+/NAA (R = 0.985, 0.869 and 0.857, 
respectively, all p values < 0.001) (Fig. 4). Using Govindaraju basis set, corrected GABA+ 
levels also significantly correlated with raw GABA+, GABA+/Cr and GABA+/NAA (R = 
0.965, 0.729 and 0.737, respectively, all p values < 0.001). Corrected GABA+ using the 
Kaiser basis set and the Govindaraju basis set were significantly different (p < 0.01). 
However, they did show a significant correlation (R = 0.858, p < 0.001). For all raw and 
corrected measurements, using the Kaiser basis set yielded smaller GABA values and higher 
inter-individual CVs than using the Govindaraju basis set, as shown by pairwise Wilcoxon 
signed ranks tests (both p < 0.01). No significant difference was seen in intra-individual CVs 
between the two basis sets. Table 4 shows percentages of tissue compositions of all 4 VOIs. 
No significant difference was observed between left and right cortical or dentate voxel 
composition.
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DISCUSSION
Our results demonstrate the feasibility of cerebellar GABA-edited spectroscopy at 3.0 Tesla 
in an elderly population with a mean age of 75.2 years. In general, using the Kaiser basis set 
yielded smaller GABA+ values than using the Govindaraju basis set, which should be due to 
the fact that Kaiser et al. considered realistic experimental issues such as volume selection, 
radiofrequency pulse shapes, editing efficiency, etc., leading to significant signal loss 
compared to ideal conditions. No significant difference in intra-individual CVs was 
observed between using the two basis sets. However, inter-individual CVs were higher using 
the Kaiser basis set. This could be due to mean GABA+ values being lower using the Kaiser 
basis set, resulting in a smaller denominator for calculating inter-individual CVs and thus 
higher CVs (corrected GABA+ (mean ± SD): 1.10 ± 0.23 for Kaiser basis set while 1.46 ± 
0.21 for Govindaraju basis set).
Two recent studies have shown GABA-edited spectra in the cerebellar vermis and left 
cerebellum in a younger healthy population (mean age: 24.6 and 43.5 years, GABA+/Cr 
0.23 ± 0.06 and 0.21 ± 0.09, respectively) (52,53). Our GABA+/Cr levels were found to be 
in similar ranges—in the left cerebellum, corrected GABA+/Cr value was 0.22 ± 0.05 using 
the Kaiser basis set and 0.30 ± 0.04 using the Govindaraju basis set; while averaged left and 
right cerebellar GABA+/Cr was 0.23 ± 0.05 using the Kaiser basis set and 0.31± 0.05 using 
the Govindaraju basis set. In the literature no change or increased Cr were found (54,55), 
while no change or decreased GABA were reported in older subjects (22–24,56). GABA
+/Cr values calculated with the Kaiser basis set were more similar with the reported 
GABA/Cr values in a young population, whereas the GABA+/Cr levels calculated with the 
Govindaraju basis set were slightly higher than that in younger populations. If using 
literature values as gold standard, this finding may reflect the fact that Kaiser et al. actually 
refined GABA chemical shifts and J-coupling values compared to Govindaraju et al. Yet, it 
is unknown what chemical shifts and/or coupling constants were used for the reported 
values. Therefore, direct comparison may be problematic. The current study suggests that 
one needs to be aware of the different outcomes when using these basis sets. It is important 
for the authors to report how their basis sets were simulated and comparisons with literature 
values must take this difference into account. It is worth mentioning that there was still a 
significant correlation between GABA levels obtained from both basis sets.
Corrected NAA levels in our study were lower than corrected Cr levels in all 4 VOIs. 
Guerrini et al. (57) reported corrected NAA/Cr = 0.79 ± 0.17 in a VOI that included the 
superior cerebellar vermis from 29 healthy subjects (age 37 ± 11 years). Our mean corrected 
NAA/Cr was 0.73 ± 0.09 in the cerebellar cortex, a similar VOI to their VOI. In addition, 
mean raw NAA/Cr can be derived as 1.08 in the cerebellum of elderly subjects from Zahr et 
al. (54), while our mean raw NAA/Cr was 1.00 ± 0.11 in a similar VOI in the dentate 
nucleus. The currently reported intra- and inter-individual CVs of cerebellar NAA and Cr 
are also in close agreement with previous reports (58,59). It is worthwhile noting here that 
different investigators, and hence different studies, may use different acquisition parameters, 
voxel sizes/placements and spectra quantification tools. Thus, absolute values are difficult to 
directly compare with each other; even metabolite ratios may differ slightly without real 
physiological cause.
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The asymmetry between left and right cerebellar cortical NAA levels is in line with two 
previous reports on higher NAA in the left prefrontal cortex and left thalamus from healthy 
subjects (60,61). In fact, a greater neuronal density was observed in the left than in the right 
hemisphere in the literature (62,63). The current correlation between NAA and Glu in the 
cerebellar cortex, but not in the dentate, is in general agreement with Waddell et al. (52), 
because their cerebellar vermis VOI contained more cortical regions.
The reproducibility studies on GABA MRS in younger adult populations reported intra-
individual CVs for GABA+ to be between 3.5 % and 20.4 %, whereas inter-individual CVs 
were between 9.1 % and 38 %, depending on different brain regions, acquisition and 
analysis techniques (25–32). It is important to mention that three of these reports appear not 
to have corrected for CSF contamination, however, they did not necessarily have higher 
CVs. Despite being conducted in an elderly study population, our corrected GABA+ showed 
similar reproducibility results (mean intra-individual CVs between 4.0 % and 13.4 % and 
inter-individual CVs between 12.6 % and 24.2 %). Though supposed to be corrected for 
inter-individual differences in neuronal density and atrophy, CSF- and relaxation-corrected 
GABA+ levels still significantly correlated with raw GABA+, GABA+/Cr and GABA
+/NAA in the dentate nucleus calculated with both Kaiser and Govindaraju basis sets in this 
elderly population. Correction for CSF and relaxation did not improve the reproducibility 
results, which may be due to the very small CSF volume in the voxel (< 5.3 % for both 
dentate VOIs) and the larger difference in measured GABA+ values among these differently 
aged subjects (between 65 and 86 years). Nevertheless, correction would still be critical and 
considered as an important factor to control in studying older subjects, who may have 
volume loss and atrophy in the region of interest.
One major limitation of the current MEGA-PRESS sequence is macromolecular 
contamination of the GABA signal at 3.0 ppm. This could be corrected by placing the 
editing pulses at 1.9 and 1.5 ppm in order to symmetrically suppress macromolecules at 3.0 
ppm (64), but often this results in substantial suppression of GABA due to insufficient 
selectivity of the editing pulse at 3.0 Tesla. This technique is also impractical in an aged 
population, which likely has decreased GABA levels. Alternatively, the contamination 
problem could be addressed by using other sequences for acquisition or by explicitly 
modeling the macromolecules in the LCModel basis set in post-processing procedures 
(65,66). Nevertheless, the current study chose to use the original MEGA-PRESS sequence 
and direct LCModel analysis to evaluate GABA reproducibility, because of the availability 
and practicability of this approach, especially in a clinical study. Our results need to be 
interpreted as showing the short-time reproducibility of measuring the sum of GABA, 
homocarnosine and co-edited macromolecules in the cerebellum of an elderly population. In 
addition, our basis sets were created assuming ideal pulses, therefore, they actually 
correspond to the center point in the voxel. Consequently the resulting quantification would 
slightly overestimate true metabolite levels due to spatial variation in excitation, refocusing, 
and chemical shift misregistration.
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CONCLUSIONS
In summary, our results demonstrated the feasibility of cerebellar GABA-edited MRS at 3.0 
Tesla in an elderly population. All GABA measurements yielded reproducible estimates 
using the MEGA-PRESS sequence, with the approach using the Kaiser basis set yielding 
quantification results of GABA+/Cr that were most consistent with literature reports. With a 
small CSF percentage in the dentate VOIs and a large range in age amongst the elderly 
subjects (~20 years), correction for CSF contamination and relaxation did not improve the 
reproducibility results. Corrected GABA+ levels significantly correlated with uncorrected 
GABA+ measurements. These results might be helpful for any study that uses this technique 
to examine GABA changes in normal or diseased aging brain, e.g., for power calculation 
and interpretation of longitudinal observations.
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Figure 1. 
Representative right cerebellar cortex (A) and dentate (B) voxel placements on T2-weighted 
coronal and axial slices. Short TE data were obtained from both VOIs, whereas GABA 
spectra were only obtained from the dentate VOIs. (C) shows pairs of repeated right 
cerebellar dentate GABA-edited difference spectra. Good visual correspondence was 
observed between the repeated measurements.
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Figure 2. 
Representative tissue segmentation of the cerebellum: (A) T2-weighted image showing the 
right cerebellar dentate VOI from Figure 1. (B), (C) and (D) show white matter, gray matter 
and cerebrospinal fluid maps of the same slice, respectively.
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Figure 3. 
GABA+ levels corrected for tissue composition and relaxation effects in left and right 
cerebellar dentate VOIs from all subjects. 5 subjects underwent 1st and 2nd scans in order to 
assess short-term reproducibility.
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Figure 4. 
Scatter plots of correlation between corrected GABA+ and raw GABA+ using the Kaiser 
basis set (Left) and corrected GABA+ between using Kaiser and Govindaraju basis sets 
(Right), obtained from LCModel analysis, with a 95 % confidence interval.
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Table 4
Relative voxel tissue composition in 4 volumes of interest--left and right cerebellar dentate and cortex, from 
all subjects (Mean ± SD (range)).
Left Cerebellar Dentate Right Cerebellar Dentate Left Cerebellar Cortex Right Cerebellar Cortex
GM 54.3±3.5 (47.8 ~ 61.0) 52.0±3.7 (45.8 ~ 58.9) 62.6±6.3 (50.9 ~ 70.8) 59.5±6.9 (50.9 ~ 72.4)
WM 40.5±3.7 (31.7 ~ 45.2) 45.0±4.1 (35.1 ~ 49.3) 33.9±7.3 (23.2 ~ 47.9) 37.8±9.0 (15.2 ~ 47.4)
CSF 5.2±2.6 (2.3 ~ 11.9) 3.0±1.5 (1.4 ~ 6.0) 3.5±2.6 (0.8 ~ 8.7) 2.7±3.0 (0.3 ~ 12.4)
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